|
1
|
Rhodes A, Evans LE, Alhazzani W, Levy MM,
Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally
ME, et al: Surviving sepsis campaign: International guidelines for
management of sepsis and septic shock: 2016. Intensive Care Med.
43:304–377. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berthelsen LO, Kristensen AT and Tranholm
M: Animal models of DIC and their relevance to human DIC: A
systematic review. Thromb Res. 128:103–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schouten M, Wiersinga WJ, Levi M and van
der Poll T: Inflammation, endothelium, and coagulation in sepsis. J
Leukoc Biol. 83:536–545. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Levi M and van der Poll T: Coagulation and
sepsis. Thromb Res. 149:38–44. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simmons J and Pittet JF: The coagulopathy
of acute sepsis. Curr Opin Anaesthesiol. 28:227–236. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu XL, Wang XZ, Liu XX, Hao D, Jaladat Y,
Lu F, Sun T and Lv CJ: Low-dose heparin as treatment for early
disseminated intravascular coagulation during sepsis: A prospective
clinical study. Exp Ther Med. 7:604–608. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rehberg S, Yamamoto Y, Sousse LE, Jonkam
C, Zhu Y, Traber LD, Cox RA, Prough DS, Traber DL and Enkhbaatar P:
Antithrombin attenuates vascular leakage via inhibiting neutrophil
activation in acute lung injury. Crit Care Med. 41:e439–e446. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tipoe TL, Wu WK, Chung L, Gong M, Dong M,
Liu T, Roever L, Ho J, Wong MC, Chan MT, et al: Plasminogen
activator inhibitor 1 for predicting sepsis severity and mortality
outcomes: A systematic review and meta-analysis. Front Immunol.
9:12182018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ince C, Mayeux PR, Nguyen T, Gomez H,
Kellum JA, Ospina-Tascón GA, Hernandez G, Murray P and De Backer D;
ADQI XIV Workgroup, : The endothelium in sepsis. Shock. 45:259–270.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Martin L, Koczera P, Zechendorf E and
Schuerholz T: The endothelial glycocalyx: New diagnostic and
therapeutic approaches in sepsis. Biomed Res Int. 2016:37582782016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Uchimido R, Schmidt EP and Shapiro NI: The
glycocalyx: A novel diagnostic and therapeutic target in sepsis.
Crit Care. 23:162019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sieve I, Münster-Kühnel AK and
Hilfiker-Kleiner D: Regulation and function of endothelial
glycocalyx layer in vascular diseases. Vascul Pharmacol. 100:26–33.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nadir Y, Brenner B, Zetser A, Ilan N,
Shafat I, Zcharia E, Goldshmidt O and Vlodavsky I: Heparanase
induces tissue factor expression in vascular endothelial and cancer
cells. J Thromb Haemost. 4:2443–2451. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schmidt EP, Yang Y, Janssen WJ, Gandjeva
A, Perez MJ, Barthel L, Zemans RL, Bowman JC, Koyanagi DE, Yunt ZX,
et al: The pulmonary endothelial glycocalyx regulates neutrophil
adhesion and lung injury during experimental sepsis. Nat Med.
18:1217–1223. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li X and Ma X: The role of heparin in
sepsis: Much more than just an anticoagulant. Br J Haematol.
179:389–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang C, Chi C, Guo L, Wang X, Guo L, Sun
J, Sun B, Liu S, Chang X and Li E: Heparin therapy reduces 28-day
mortality in adult severe sepsis patients: A systematic review and
meta-analysis. Crit Care. 18:5632014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wildhagen KC, García de Frutos P,
Reutelingsperger CP, Schrijver R, Aresté C, Ortega-Gómez A, Deckers
NM, Hemker HC, Soehnlein O and Nicolaes GA: Nonanticoagulant
heparin prevents histone-mediated cytotoxicity in vitro and
improves survival in sepsis. Blood. 123:1098–1101. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fodor RŞ, Georgescu AM, Cioc AD,
Grigorescu BL, Cotoi OS, Fodor P, Copotoiu SM and Azamfirei L:
Time- and dose-dependent severity of lung injury in a rat model of
sepsis. Rom J Morphol Embryol. 56:1329–1337. 2015.PubMed/NCBI
|
|
19
|
Li X, Li Z, Zheng Z, Liu Y and Ma X:
Unfractionated heparin ameliorates lipopolysaccharide-induced lung
inflammation by downregulating nuclear factor-κB signaling pathway.
Inflammation Dec. 36:1201–1208. 2013. View Article : Google Scholar
|
|
20
|
Taylor FB Jr, Toh CH, Hoots WK, Wada H and
Levi M; Scientific Subcommittee on Disseminated Intravascular
Coagulation (DIC) of the International Society on Thrombosis and
Haemostasis (ISTH), : Towards definition, clinical and laboratory
criteria, and a scoring system for disseminated intravascular
coagulation. Thromb Haemost. 86:1327–1330. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aeffner F, Bolon B and Davis IC: Mouse
models of acute respiratory distress syndrome: A review of
analytical approaches, pathologic features, and common
measurements. Toxicol Pathol. 43:1074–1092. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao D, Ding R, Liu Y, Yin X, Zhang Z and
Ma X: Unfractionated heparin protects the protein C system against
lipopolysaccharide-induced damage in vivo and in
vitro. Exp Ther Med. 14:5515–5522. 2017.PubMed/NCBI
|
|
23
|
Rizzo AN and Dudek SM: Endothelial
glycocalyx repair: Building a wall to protect the lung during
sepsis. Am J Respir Cell Mol Biol. 56:687–688. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Huang X, Kong G, Li Y, Zhu W, Xu H, Zhang
X, Li J, Wang L, Zhang Z, Wu Y, et al: Decitabine and 5-azacitidine
both alleviate LPS induced ARDS through
anti-inflammatory/antioxidant activity and protection of glycocalyx
and inhibition of MAPK pathways in mice. Biomed Pharmacother.
84:447–453. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Confalonieri M, Salton F and Fabiano F:
Acute respiratory distress syndrome. Eur Respir Rev. 26:2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen S, He Y, Hu Z, Lu S, Yin X, Ma X, Lv
C and Jin G: Heparanase mediates intestinal inflammation and injury
in a mouse model of sepsis. J Histochem Cytochem. 65:241–249. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Afratis NA, Nikitovic D, Multhaupt HA,
Theocharis AD, Couchman JR and Karamanos NK: Syndecans-key
regulators of cell signaling and biological functions. FEBS J.
284:27–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Steppan J, Hofer S, Funke B, Brenner T,
Henrich M, Martin E, Weitz J, Hofmann U and Weigand MA: Sepsis and
major abdominal surgery lead to flaking of the endothelial
glycocalix. J Surg Res. 165:136–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsao CM, Ho ST and Wu CC: Coagulation
abnormalities in sepsis. Acta Anaesthesiol Taiwan. 53:16–22. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kakkar VV, Bentley PG, Scully MF,
MacGregor IR, Jones NA and Webb PJ: Antithrombin III and heparin.
Lancet. 1:103–104. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Onishi A, St Ange K, Dordick JS and
Linhardt RJ: Heparin and anticoagulation. Front Biosci (Landmark
Ed). 21:1372–1392. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shworak NW, Kobayashi T, de Agostini A and
Smits NC: Anticoagulant heparan sulfate to not clot-or not? Prog
Mol Biol Transl Sci. 93:153–178. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vink H, Constantinescu AA and Spaan JA:
Oxidized lipoproteins degrade the endothelial surface layer:
Implications for platelet-endothelial cell adhesion. Circulation.
101:1500–1502. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chappell D, Brettner F, Doerfler N, Jacob
M, Rehm M, Bruegger D, Conzen P, Jacob B and Becker BF: Protection
of glycocalyx decreases platelet adhesion after
ischaemia/reperfusion: An animal study. Eur J Anaesthesiol.
31:474–481. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ikeda M, Matsumoto H, Ogura H, Hirose T,
Shimizu K, Yamamoto K, Maruyama I and Shimazu T: Circulating
syndecan-1 predicts the development of disseminated intravascular
coagulation in patients with sepsis. J Crit Care. 43:48–53. 2018.
View Article : Google Scholar : PubMed/NCBI
|
